Abstract:Objective: To investigate the mutation of the KRAS/NRAS/BRAF/PIK3CA gene and its relationship with clinicopathological features in colorectal cancer (CRC). Methods: The surgical resection specimens of 91 patients with primary CRC from 2012 to 2016 in Shanghai Fifth People's Hospital affiliated with Fudan University were collected for retrospective analysis. Detecting mutations in the KRAS/NRAS/BRAF/PIK3CA genes were confirmed by an amplification-refractory mutation system (ARMS). Immunohistochemistry (IHC) was conducted to confirm the expression of KRAS, NRAS, BRAF, and PIK3CA proteins.Results: Among 91 CRC patients, the mutation rates of the KRAS, NRAS, BRAF, and PIK3CA genes were 40.7% (37/91), 4.4% (4/91), 3.3% (3/91) and 2.2% (2/91), respectively. The KRAS/PIK3CA double mutation rate was 2.2% (2/91), and the KRAS/NRAS double mutation rate was 1.1% (1/91). The mutation rate of the BRAF gene in poorly differentiated CRC patients was significantly higher than that in moderately to well-differentiated patients (P < 0.05). PIK3CA gene mutation was significantly different between primary tumour sites (P < 0.05). The mutation rate of the KRNS/NRAS/BRAF/PIK3CA genes in patients with lymph node metastasis (78.3%, 18/23) was significantly higher than that in patients without lymph node metastasis (45.6%, 31/68) (P < 0.05). No significant differences in immunohistochemical expression between KRAS-, NRAS-, BRAF-, and PIK3CA-mutant patients and nonmutated patients were confirmed (P>0.05). Conclusions: KRAS mutation is the most common mutated gene in CRC patients. PIK3CA mutation is often accompanied by KRAS mutation, and EGFR treatment resistance in KRAS wild-type patients may be caused by PIK3CA gene mutation. Simultaneous detection of KRAS/NRAS/BRAF/PIK3CA gene mutations helps to develop the most accurate treatment for CRC patients. KRAS/NRAS/BRAF/PIK3CA gene mutations were associated with several clinicopathological features in this group of CRC patients, but more cases need to be confirmed by further studies. Gene mutations in CRC patients are best detected by DNA sequencing or ARMS methods.Funding Information: This work was supported by the High-level Professional Physician Training Program of Minhang District, Shanghai City (No. 2020MZYS10).Declaration of Interests: None.Ethics Approval Statement: The study was approved by the Ethical Committee of Shanghai Fifth People's Hospital, Fudan University (No. 2021071). Patients did not need to give informed consent because anonymous data were used in the analysis, which were obtained after each patient's written consent to treatment.

High Probability of Lynch Syndrome Among Colorectal Cancer Patients Is Associated With Higher Occurrence of KRAS and PIK3CA Mutations

Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer

KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer.

A Study on the Relationship Between KRAS, NRAS, BRAF and PIK3CA Gene Mutations and Clinicopathological Features in Patients with Colorectal Cancer

Frequency of KRAS and BRAF mutations in colorectal carcinoma and their association with clinical-pathological characteristics in a tertiary hospital in Kenya

KRAS Mutational Profiles among Colorectal Cancer Patients in the East Coast of Peninsular Malaysia

Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors

Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer

Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes

KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients

Identıfıcatıon of KRAS Mutatıons in Colorectal Carcınoma Patıents at Dr. M. Djamıl Hospıtal, West Sumatra-Indonesıa

KRAS and BRAF Gene Mutations and DNA Mismatch Repair Status in Chinese Colorectal Carcinoma Patients.

[KRAS and BRAF Gene Mutations in Correlation with Clinicopathologic Features of Colorectal Carcinoma in Chinese].

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer

The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway

Comprehensive analysis of gene mutations and mismatch repair in Chinese colorectal cancer patients

KRAS and BRAF genetic alterations in lung cancer: A case - control study

Clinicopathologic Distribution of KRAS and BRAF Mutations in a Chinese Population with Colorectal Cancer Precursor Lesions

Association of KRAS G12C status with age at onset of metastatic colorectal cancer in the Brazilian population: A multicenter analysis of a molecular profile database (RAS, BRAF and MSI status).

Clinicopathologic Characteristics Influencing Overall Survival of Patients With Early- Versus Average-Onset Colorectal Cancer at a Tertiary Care Center in Indonesia